Clinical Trial Update: L-Arginine Metabolism in Essential Hypertension [Phase 2, Phase 3]

View source ↗

Summary

The document reports completion of a Phase 2/Phase 3 clinical trial investigating L-Arginine metabolism in essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Essential Hypertension | Phase 2, Phase 3 | Status: COMPLETED